Intrasense, a French expert in AI-powered medical imaging solutions that facilitate diagnosis, decision-making, and therapeutic follow-up, announces the publication of its 2025 annual results. These financial statements were approved by the Board of Directors on March 10, 2026.

Intrasense, French expert in AI-enhanced medical imaging solutions that facilitate diagnosis, decision-making, announces changes to the composition of its Board of Directors.

Intrasense, French expert in AI-enhanced medical imaging solutions that facilitate diagnosis, decision-making, and therapeutic follow-up, publishes its consolidated revenue for the 2025 financial year.

Munich, Germany & Montpellier, France, January 28, 2026 - Abdominal CT is one of the biggest pressure points in radiology. High volumes, long reading lists, and complex oncology follow-up cases make it challenging to ensure both accurate and timely reporting. When subtle liver, bone, or pancreatic findings remain buried in thousands of slices, small oversights can slow entire pathways. Intrasense is addressing this operational reality with DUOnco™, a suite of three standalone AI solutions co-developed with Guerbet that support earlier lesion visibility inside everyday workflows. Intrasense and deepc are partnering to make these solutions available through deepcOS®.

Intrasense, a French expert in medical imaging solutions that facilitate and secure diagnostics, decision-making, and therapeutic follow-up, announces the appointment of Mr. Stephen Armand as Chief Executive Officer of the Company.